학술논문
Primary Results on Safety and Efficacy From the LEADLESS II–Phase 2 Worldwide Clinical Trial
Document Type
Correspondence
Author
Source
In JACC: Clinical Electrophysiology January 2022 8(1):115-117
Subject
Language
ISSN
2405-500X